Generate Biomedicines
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GENB and other ETFs, options, and stocks.About GENB
Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.
CEOMichael T. Nally
CEOMichael T. Nally
Employees312
Employees312
HeadquartersSomerville, Massachusetts
HeadquartersSomerville, Massachusetts
Founded2018
Founded2018
Employees312
Employees312
GENB Key Statistics
Market cap1.70B
Market cap1.70B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today$15.32
High today$15.32
Low today$13.25
Low today$13.25
Open price$15.00
Open price$15.00
Volume2.23M
Volume2.23M
52 Week high—
52 Week high—
52 Week low—
52 Week low—
Stock Snapshot
As of today, Generate Biomedicines(GENB) shares are valued at $13.35. The company's market cap stands at 1.7B.
On 2026-02-27, Generate Biomedicines(GENB) stock traded between a low of $13.25 and a high of $15.32. Shares are currently priced at $13.35, which is +0.7% above the low and -12.9% below the high.
Generate Biomedicines(GENB) shares are trading with a volume of 2.23M.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.